US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Hillstream BioPharma Inc (HILS)
Hillstream BioPharma Inc (HILS) ニュース

HILS

Hillstream BioPharma (HILS)

Hillstream BioPharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:HILS

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/03/23	00 : 12	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HILS	Hillstream BioPharma Inc
2024/03/23	00 : 08	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:HILS	Hillstream BioPharma Inc
2024/03/22	06 : 27	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HILS	Hillstream BioPharma Inc
2024/03/22	06 : 25	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:HILS	Hillstream BioPharma Inc
2023/09/26	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HILS	Hillstream BioPharma Inc
2023/09/21	22 : 35	GlobeNewswire Inc.	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference	NASDAQ:HILS	Hillstream BioPharma Inc
2023/09/12	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HILS	Hillstream BioPharma Inc
2023/09/12	00 : 51	GlobeNewswire Inc.	Hillstream Enters into an Exclusive Option Agreement to Acquire a Clinical Stage Asset for Chronic Pruritis	NASDAQ:HILS	Hillstream BioPharma Inc
2023/09/09	03 : 30	GlobeNewswire Inc.	Hillstream BioPharma to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13	NASDAQ:HILS	Hillstream BioPharma Inc
2023/08/31	06 : 22	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HILS	Hillstream BioPharma Inc
2023/08/31	06 : 20	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:HILS	Hillstream BioPharma Inc
2023/08/19	06 : 15	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:HILS	Hillstream BioPharma Inc
2023/08/12	05 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HILS	Hillstream BioPharma Inc
2023/08/09	21 : 47	GlobeNewswire Inc.	Hillstream BioPharma to Present at the Sidoti Micro-Cap Virtual Conference on August 16-17, 2023	NASDAQ:HILS	Hillstream BioPharma Inc
2023/07/20	21 : 00	GlobeNewswire Inc.	Hillstream Advances Next-Gen Multispecific Antibodies for Solid Tumors with Lead HER2/HER3 Program, HSB-3215	NASDAQ:HILS	Hillstream BioPharma Inc
2023/07/18	05 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HILS	Hillstream BioPharma Inc
2023/07/12	06 : 25	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HILS	Hillstream BioPharma Inc
2023/07/10	21 : 47	GlobeNewswire Inc.	Hillstream BioPharma Announces Strategic Reprioritization of Pipeline to Targeting HER2/HER3 Solid Tumors via Bispecific and ADC Antibodies and Biologics	NASDAQ:HILS	Hillstream BioPharma Inc
2023/07/06	21 : 30	GlobeNewswire Inc.	Hillstream BioPharma Licenses Technology to Develop Proprietary HER2 and HER3 Antibody Drug Conjugates against Drug-Resistant Breast, Lung, Gastric, and Ovarian Cancers	NASDAQ:HILS	Hillstream BioPharma Inc
2023/06/21	05 : 55	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/06/17	05 : 16	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/22	19 : 01	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/22	19 : 01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/22	19 : 01	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/17	05 : 16	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/16	05 : 23	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/16	05 : 21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/15	21 : 47	GlobeNewswire Inc.	Hillstream BioPharma Strengthens its Board of Directors with Appointment of Kelly Anderson	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/03	05 : 05	GlobeNewswire Inc.	Hillstream BioPharma Announces Closing of Public Offering of Common Stock	NASDAQ:HILS	Hillstream BioPharma Inc
2023/05/02	21 : 47	GlobeNewswire Inc.	Hillstream BioPharma to Present at Upcoming May 2023 Investor and Industry Conferences	NASDAQ:HILS	Hillstream BioPharma Inc

Showing the most relevant articles for your search:NASDAQ:HILS

1 2 3 次へ >>

Citigroup Global Markets...

T Rex 2X Long Microsoft ...

Cdp Tf 2,428% Mz33 Eur

Vendetta Mining Corporate (PK)

Strathmore Plus Energy

Ishr E Gv 7-10a

Nuveen Growth Opportunit...

Biome Grow (PK)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約